Date Created: 19 December 2011
Montrose based pharmaceutical giant, GlaxoSmithKline, has received a £1.46 million Research and Development grant from Scottish Enterprise.
The grant will be used to create up to 25 new jobs as well as position the site as a future new product development facility.
Andy Ross, Site Director said: "We are very grateful to Scottish Enterprise for all their efforts in relation to the R&D grant.
"Their financial support will allow us to provide the right people, plant and expertise at a critical time for the GSK Montrose site as we look to introduce innovative new processes so as to maintain our global cost effectiveness.
"This forms a key part of our future development and sustainability."
Finance Secretary John Swinney announced the funding when he visited the Montrose facility.
He said: "The Scottish Government and our enterprise agencies are doing all we can to build sustainable economic growth for Scotland.
"This investment by GlaxoSmithKline in Montrose is looking towards the future and I'm encouraged that a world leading company is showing this commitment to the area."
Linda Hanna, Director of Company Growth at Scottish Enterprise, added:
“In the current economic conditions, it’s critical that more companies continue to innovate so that the Scottish economy maintains its competitive edge. This R&D grant will allow GlaxoSmithKline to do just that, by increasing efficiencies and introducing new products to its Montrose site."
Find out more about pharmaceuticals in Scotland